tranexamic acid has been researched along with Transfusion Reaction in 22 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Transfusion Reaction: Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.
Excerpt | Relevance | Reference |
---|---|---|
" There have been many changes in the management of massive hemorrhage, for example, the administration of the tranexamic acid and the use of balanced transfusion ratio." | 4.93 | [Management of bleeding and coagulopathy following major trauma]. ( Etxaniz, A; Pita, E, 2016) |
" The ongoing trials create six new comparisons: tranexamic acid (tablet + injection) versus placebo; intravenous tranexamic acid versus oral tranexamic acid; topical tranexamic acid versus oral tranexamic acid; different intravenous tranexamic acid dosing regimes; topical tranexamic acid versus topical fibrin glue; and fibrinogen (injection) versus placebo." | 3.01 | Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures. ( Brunskill, SJ; Champaneria, R; Dorée, C; Estcourt, LJ; Geneen, LJ; Gibbs, VN; Novak, A; Palmer, AJ; Raval, P, 2023) |
"Several methods reportedly reduce postoperative blood loss and avoid homologous blood transfusion with traditional TKA approaches, but it is unclear these reductions apply to a minimally invasive technique." | 2.76 | Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. ( Charoencholvanich, K; Siriwattanasakul, P, 2011) |
"Tranexamic acid (TXA) is an antifibrinolytic agent that reduces bleeding and transfusion in a broad number of adult and pediatric surgeries, as well as in trauma and obstetrics." | 2.61 | Tranexamic acid and perioperative bleeding in children: what do we still need to know? ( Faraoni, D; Goobie, SM, 2019) |
"Tranexamic acid was introduced during these procedures in 2006." | 1.43 | Use of Tranexamic Acid Is Associated with Reduced Blood Product Transfusion in Complex Skull Base Neurosurgical Procedures: A Retrospective Cohort Study. ( Akagami, R; Flexman, AM; Mebel, D, 2016) |
"The incidence of symptomatic deep vein thrombosis and pulmonary embolism was evaluated." | 1.43 | Tranexamic Acid Can Be Administered to Arthroplasty Patients Who Receive Aspirin for Venous Thromboembolic Prophylaxis. ( Chen, AF; Heller, S; Parvizi, J; Secrist, E; Shahi, A, 2016) |
"Blood conservation; the area of greatest clinical variability was seen in dosing regimes for Tranexamic acid." | 1.37 | Blood conservation and pain control in scoliosis corrective surgery: an online survey of UK practice. ( Bird, S; McGill, N, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (13.64) | 29.6817 |
2010's | 18 (81.82) | 24.3611 |
2020's | 1 (4.55) | 2.80 |
Authors | Studies |
---|---|
Gibbs, VN | 1 |
Geneen, LJ | 1 |
Champaneria, R | 1 |
Raval, P | 1 |
Dorée, C | 1 |
Brunskill, SJ | 1 |
Novak, A | 1 |
Palmer, AJ | 1 |
Estcourt, LJ | 1 |
Cybulska, P | 1 |
Goss, C | 1 |
Tew, WP | 1 |
Parameswaran, R | 1 |
Sonoda, Y | 1 |
Goobie, SM | 1 |
Faraoni, D | 1 |
Muñoz Gómez, M | 2 |
Páramo Fernández, JA | 2 |
Engelbrecht, S | 1 |
Wood, EM | 1 |
Cole-Sinclair, MF | 1 |
Maciel, JD | 1 |
Gifford, E | 1 |
Plurad, D | 1 |
de Virgilio, C | 1 |
Bricker, S | 1 |
Bongard, F | 1 |
Neville, A | 1 |
Smith, J | 1 |
Putnam, B | 1 |
Kim, D | 1 |
Gao, F | 1 |
Sun, W | 1 |
Guo, W | 1 |
Li, Z | 1 |
Wang, W | 1 |
Cheng, L | 1 |
Etxaniz, A | 1 |
Pita, E | 1 |
Bisbe Vives, E | 1 |
Basora Macaya, M | 1 |
García Erce, JA | 1 |
Gómez Luque, A | 1 |
Leal-Noval, SR | 1 |
Colomina, MJ | 1 |
Comin Colet, J | 1 |
Contreras Barbeta, E | 1 |
Cuenca Espiérrez, J | 1 |
Garcia de Lorenzo Y Mateos, A | 1 |
Gomollón García, F | 1 |
Izuel Ramí, M | 1 |
Moral García, MV | 1 |
Montoro Ronsano, JB | 1 |
Pereira Saavedra, A | 1 |
Quintana Diaz, M | 1 |
Remacha Sevilla, Á | 1 |
Salinas Argente, R | 1 |
Sánchez Pérez, C | 1 |
Tirado Anglés, G | 1 |
Torrabadella de Reinoso, P | 1 |
Bagsby, DT | 1 |
Samujh, CA | 1 |
Vissing, JL | 1 |
Empson, JA | 1 |
Pomeroy, DL | 1 |
Malkani, AL | 1 |
Mebel, D | 1 |
Akagami, R | 1 |
Flexman, AM | 1 |
Kopanidis, P | 1 |
Hardidge, A | 1 |
McNicol, L | 1 |
Tay, S | 1 |
McCall, P | 1 |
Weinberg, L | 1 |
Heller, S | 1 |
Secrist, E | 1 |
Shahi, A | 1 |
Chen, AF | 1 |
Parvizi, J | 1 |
Tzatzairis, TK | 1 |
Drosos, GI | 1 |
Kotsios, SE | 1 |
Ververidis, AN | 1 |
Vogiatzaki, TD | 1 |
Kazakos, KI | 1 |
Soroceanu, A | 1 |
Oren, JH | 1 |
Smith, JS | 1 |
Hostin, R | 1 |
Shaffrey, CI | 1 |
Mundis, GM | 1 |
Ames, CP | 1 |
Burton, DC | 1 |
Bess, S | 1 |
Gupta, MC | 1 |
Deviren, V | 1 |
Schwab, FJ | 1 |
Lafage, V | 1 |
Errico, TJ | 1 |
Rosencher, N | 1 |
Bellamy, L | 1 |
Chabbouh, T | 1 |
Arnaout, L | 1 |
Ozier, Y | 1 |
Bird, S | 1 |
McGill, N | 1 |
Anderson, L | 1 |
Charoencholvanich, K | 1 |
Siriwattanasakul, P | 1 |
Watts, CD | 1 |
Pagnano, MW | 1 |
Pleym, H | 1 |
Katz, E | 1 |
Gaitini, L | 1 |
Samri, M | 1 |
Egoz, N | 1 |
Fergusson, D | 1 |
Laupacis, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery: A Double-Blind Randomized Controlled Trial[NCT04863339] | Phase 2 | 0 participants (Actual) | Interventional | 2022-03-31 | Withdrawn (stopped due to Challenges in recruitment) | ||
Efficacy of Tranexamic Acid in Femoral Shaft Fractures Osteosynthesis; A Double Blind Randomized Controlled Trial[NCT04803591] | Phase 4 | 0 participants (Actual) | Interventional | 2021-08-01 | Withdrawn (stopped due to Not approved by Ethics Commettee) | ||
Role of Topical Tranexamic Acid in Total Hip Arthroplasty[NCT01866943] | Phase 2 | 41 participants (Actual) | Interventional | 2011-11-30 | Terminated | ||
Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty: A Randomized Controlled Trial[NCT02829346] | Phase 2 | 60 participants (Actual) | Interventional | 2012-10-31 | Completed | ||
Evaluation of Efficacy and Safety of Perioperative Tranexamic Acid During Primary Total Knee Arthroplasty: A Randomized, Clinical Trial[NCT05919615] | 100 participants (Actual) | Interventional | 2021-07-15 | Completed | |||
Serial Use of Intravenous and Oral Tranexamic Acid in Primary Total Knee Arthroplasty Patients: A Randomized Controlled Study[NCT03109652] | Phase 4 | 144 participants (Anticipated) | Interventional | 2017-07-10 | Recruiting | ||
Evaluation of the Pharmacokinetic Profile of Tranexamic Acid, After Injection in a Knee Neo-articulation.[NCT02319915] | Early Phase 1 | 14 participants (Actual) | Interventional | 2015-02-18 | Completed | ||
Evaluation of the Use of Tranexamic Acid in Tibial Osteotomies: a Randomised Controlled Clinical Trial.[NCT04785651] | 84 participants (Anticipated) | Interventional | 2021-02-22 | Recruiting | |||
Efficacy and Safety of Erythropoietin And/Or Intravenous Iron Sucrose For Treatment of Anemia In Hip and Knee Arthroplasty: A Single-center Retrospective Study[NCT03917394] | 780 participants (Anticipated) | Observational | 2019-04-24 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Estimated Blood Loss defined as Pre Op Hgb mins the Post Op Day two Hgb. (NCT01866943)
Timeframe: Pre Op, Post Op Day 2
Intervention | Hemoglobin (grams/deciliter) (Mean) |
---|---|
Baseline Population | 2.93 |
Standardized questionnaire that measures clinical function related to the hip. Total potential range is from 4.0 - 96.0. A higher score indicates a more favorable clinical outcome. (NCT01866943)
Timeframe: 2 week
Intervention | units on a scale (Mean) |
---|---|
All Study Participants | 65.76 |
Standardized questionnaire that measures clinical function related to the hip. Total potential range is from 4.0 - 96.0. A higher score indicates a more favorable clinical outcome. (NCT01866943)
Timeframe: 6 week
Intervention | units on a scale (Mean) |
---|---|
All Study Participants | 81.77 |
Standardized questionnaire that measures clinical function related to the hip. Total potential range is from 4.0 - 96.0. A higher score indicates a more favorable clinical outcome. (NCT01866943)
Timeframe: Preoperative
Intervention | units on a scale (Mean) |
---|---|
All Study Participants | 58.34 |
Measurement of the thigh at the half way point between the prominence of the greater trochanter and the lateral epicondyle of the femur. No data recorded at 2 weeks or 6 weeks for this study population. (NCT01866943)
Timeframe: Pre Op
Intervention | centimeters (Mean) |
---|---|
Baseline Population | 52.99 |
6 reviews available for tranexamic acid and Transfusion Reaction
Article | Year |
---|---|
Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures.
Topics: Arthroplasty, Replacement; Fibrinogen; Fractures, Bone; Hemorrhage; Hemostatics; Humans; Myocardial | 2023 |
Indications for and complications of transfusion and the management of gynecologic malignancies.
Topics: Acute Lung Injury; Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Erythrocyte Transfusion; F | 2017 |
Tranexamic acid and perioperative bleeding in children: what do we still need to know?
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Child; Dose-Response Relationship, | 2019 |
[Management of bleeding and coagulopathy following major trauma].
Topics: Blood Coagulation Disorders; Hemorrhage; Humans; Multiple Trauma; Tranexamic Acid; Transfusion React | 2016 |
[Blood conservation approaches in orthopedic surgery].
Topics: Anemia; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Drug Admi | 2008 |
Minimising blood loss and transfusion in contemporary hip and knee arthroplasty.
Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bl | 2012 |
3 trials available for tranexamic acid and Transfusion Reaction
Article | Year |
---|---|
Topical Administration of Tranexamic Acid Plus Diluted-Epinephrine in Primary Total Knee Arthroplasty: A Randomized Double-Blinded Controlled Trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blin | 2015 |
Intravenous vs Topical Tranexamic Acid in Total Knee Arthroplasty Without Tourniquet Application: A Randomized Controlled Study.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2016 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
13 other studies available for tranexamic acid and Transfusion Reaction
Article | Year |
---|---|
[Intravenous administration of tranexamic acid to decrease bleeding and transfusion in knee and hip prosthetic surgery: is it safe and cost-effective?].
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Cost-Benefit | 2013 |
Clinical transfusion practice update: haemovigilance, complications, patient blood management and national standards.
Topics: Acute Lung Injury; Anticoagulants; Antifibrinolytic Agents; Australia; Blood Transfusion; Clinical P | 2013 |
The impact of a massive transfusion protocol on outcomes among patients with abdominal aortic injuries.
Topics: Abdominal Injuries; Accidents, Traffic; Adolescent; Adult; Antifibrinolytic Agents; Aorta, Abdominal | 2015 |
Forum for debate: Safety of allogeneic blood transfusion alternatives in the surgical/critically ill patient.
Topics: Anemia; Antifibrinolytic Agents; Aprotinin; Blood Coagulation Factors; Blood Transfusion; Clinical T | 2015 |
Tranexamic Acid Decreases Incidence of Blood Transfusion in Simultaneous Bilateral Total Knee Arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2015 |
Use of Tranexamic Acid Is Associated with Reduced Blood Product Transfusion in Complex Skull Base Neurosurgical Procedures: A Retrospective Cohort Study.
Topics: Antifibrinolytic Agents; Blood Transfusion; Cohort Studies; Erythrocyte Transfusion; Female; Hemoglo | 2016 |
Perioperative blood management programme reduces the use of allogenic blood transfusion in patients undergoing total hip and knee arthroplasty.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replaceme | 2016 |
Tranexamic Acid Can Be Administered to Arthroplasty Patients Who Receive Aspirin for Venous Thromboembolic Prophylaxis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty; Aspirin; Blood Loss, Surgical; Cohort Studies; Female; | 2016 |
Effect of Antifibrinolytic Therapy on Complications, Thromboembolic Events, Blood Product Utilization, and Fusion in Adult Spinal Deformity Surgery.
Topics: Adult; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Humans; Male; | 2016 |
Blood conservation and pain control in scoliosis corrective surgery: an online survey of UK practice.
Topics: Adolescent; Analgesia, Epidural; Analgesics, Opioid; Anesthesia; Anticoagulants; Antifibrinolytic Ag | 2011 |
Blood conservation in cardiac surgery.
Topics: Algorithms; Aprotinin; Blood Loss, Surgical; Blood Substitutes; Blood Transfusion; Cardiac Surgical | 2010 |
[Drugs to reduce transfusion needs during surgery].
Topics: Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Auto | 2008 |
The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel.
Topics: Aprotinin; Attitude of Health Personnel; Biomedical Technology; Blood Loss, Surgical; Blood Transfus | 2001 |